Depression

Select from the various topics below and click on the link to get an inside view of how our P&T committee responded to the issue. 

Discussion: Abilify

Analysis of HEDIS Measures

Clinical Discussion Emsam Efficacy

Clinical Discussion Wellbutrin XL

Comparing SSRIs to MAO Utilization

The Cost of Emsam

Vote: Cymbalta and EffexorXR

Discussion: PA SE For Wellbutrin vs. Moving To Tier 2

Emsam Clinical Discussion (Trial Size)

Emsam Discussion of Transdermal Delivery

Emsam Efficacy Discussion

Emsam Comparison To Oral MAOI

Financial Discussion DACON of EffexorXR vs. Cymbalta

Impact of Pill Splitting Policy on Cost

Discussion: Impact of Side Effects Effexor vs. Cymbalta

Rebate Discussion Cymbalta vs. Wellbutrin

SAD vs. Bipolar

Toxicity of Effexor

Vote: Emsam PA Criteria

Vote: Quantity Limits For Emsam

Vote: Lexapro For Non-Formulary and PA

Vote: Lexapro PA and Form Placement

Vote: PA Ensam

Vote: PA Zoloft vs. Generics

Vote: To Add PA and Formulary Placement For Ensam

Vote: Wellbutrin XL and Step Edits

Wellbutrin XL SAD Study Validity Question

Wellbutrin XL SAD Effectiveness Rates

Wellbutrin XL Comparison of Various Treatments

Wellbutrin XR Aggressive Rebate Offer

Discussion: Wyeth Contracting

* PTP video clips play in windows media player.  To download click here, Mac users click here
 

top of page